摘要
目的研究低分子肝素钠治疗淤胆型肝炎的疗效及安全性。方法将77例患者按随机分配表分为治疗组、对照组,治疗组应用低分子肝素钠,对照组应用腺苷蛋氨酸,2组均应用一般支持治疗。结果2组有效率分别为88.6%、86.4%,2组比较χ2=2.63,P>0.05,差异无统计学意义。治疗组患者凝血酶原时间治疗前、后无明显变化,无1例出现出血倾向。结论低分子肝素钠治疗淤胆型肝炎疗效好,安全性好,价格低,适合各级医院,值得临床推广。
Objective To investigate the effectiveness and security of low molecular weight heparins in the treatment of patients with eholestatie hepatitis, Methods 77 patients were randomly divided into two groups： control group and low molecular weight heparins treatment group .44 patients were given low molecular weight heparins injection, 43 control group patients were given Ademetionine 1,4-Butanedisufonate for injection, and the same support care was also given to the two groups, Results The rate of effieieney in the low molecular weight heparins the treatment group was 88.6% vs 86,4% ,P〉0.05.Conclusions Our results suggest that low molecular weight heparins administration with conventional supporting treatment has a good effect and security in patients with eholestatie hepatitis.
出处
《基层医学论坛》
2007年第8期675-676,共2页
The Medical Forum
关键词
淤胆型肝炎
低分子肝素
Cholestasis hepatitis Low molecular weight heparins
